Rani completes first trial of capsule that could replace injections

Backed by Google’s parent company Alphabet, Rani has begun clinical trials of the RaniPill, which is capable of delivering biologic drugs such as insulin and AbbVie’s Humira into the wall of the small intestine. Rani has already conducted more than 100 animal studies and found the pill showed 100% equivalence with injections. The RaniPill capsule has a special enteric coating that protects itself in the acidic environment of the stomach.
Read more...

;